Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.560
0.000
Volume:4.22M
Turnover:19.27M
Market Cap:28.65B
PE:7.76
High:4.580
Open:4.570
Low:4.550
Close:4.560
52wk High:5.668
52wk Low:4.486
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:0.53
T/O Rate:0.07%
Dividend:0.14
Dividend Rate:3.01%
EPS(LYR):0.588
ROE:7.57%
ROA:2.66%
PB:0.52
PE(LYR):7.76
PS:0.10

Loading ...

China Resources Pharmaceutical Group (3320) Completes First Tranche of 2025 Corporate Bonds in the PRC

Bulletin Express
·
Oct 21

CHINARES PHARMA (03320) Completes Issuance of RMB 1.1 Billion Corporate Bonds

Stock News
·
Oct 21

China Resources Pharmaceutical Group Issues RMB1.1 Billion Three-Year Corporate Bonds

Reuters
·
Oct 21

A Look At The Fair Value Of China Resources Pharmaceutical Group Limited (HKG:3320)

Simply Wall St.
·
Sep 28

China Resources Pharmaceutical Group Ltd. Reports 1.3% Year-on-Year Decline in Revenue and 4.7% Drop in Net Profit for 1H 2025; EPS at RMB0.33

Reuters
·
Sep 26

China Resources Pharmaceutical Group Ltd. Announces Release of 2025 Interim Report

Reuters
·
Sep 26

China Resources Pharmaceutical Group Ltd. Announces Interim Dividend of RMB0.072 Per Share for Six Months Ended 30 June 2025

Reuters
·
Sep 23

CHINARES PHARMA (03320): Liu Chang'an Appointed as Executive Director

Stock News
·
Sep 18

China Resources Pharmaceutical Group Ltd - Deng Rong Resigned as an Executive Director

THOMSON REUTERS
·
Sep 18

CHINARES PHARMA Completes Compensation System Optimization Project Review Following Cheng Jie's Appointment as Group President

Deep News
·
Sep 17

CMSC Lowers CHINARES PHARMA (03320) Target Price to HK$5.9, Maintains "Overweight" Rating

Stock News
·
Sep 02

China Resources Pharmaceutical Could Outperform Sinopharm's Growth -- Market Talk

Dow Jones
·
Aug 27

China Resources Pharmaceutical Appoints New President

MT Newswires Live
·
Aug 26

China Resources Pharmaceutical's H1 Profit Drops

MT Newswires Live
·
Aug 26

BRIEF-China Resources Pharmaceutical Group Posts H1 Net Income RMB 5,053.6 Million

Reuters
·
Aug 26

CHINARES PHARMA (03320): Cheng Jie Appointed as Executive Director and President

Stock News
·
Aug 26

China Resources Pharmaceutical Group H1 Gross Profit RMB 21,509.6 Million

THOMSON REUTERS
·
Aug 26

China Resources Pharmaceutical Group Ltd - Tao Ran Resigns as Executive Director

THOMSON REUTERS
·
Aug 26

BRIEF-China Resources Pharmaceutical Posts HY Revenue RMB1.01 Bln For CR Boya Bio-Pharmaceutical

Reuters
·
Aug 22

BRIEF-China Resources Pharmaceutical Reports HY Net Profit Attributable For CR Double-Crane RMB975.5 Million

Reuters
·
Aug 22